logo
logo
SEER stock ticker logo

Seer, Inc.

NASDAQ•SEER
CEO: Dr. Omid C. Farokhzad M.D., Ph.D.
セクター: Healthcare
業種: Biotechnology
上場日: 2020-12-04
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company intends to sell its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It operates in China, Australia, Eastern Europe, Israel, and Japan. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.
連絡先情報
3800 Bridge Parkway, Suite 102, Redwood City, CA, 94065, United States
650-453-0000
seer.bio
時価総額
$94.57M
PER (TTM)
-1.4
24.5
配当利回り
--
52週高値
$2.41
52週安値
$1.65
52週レンジ
9%
順位54Top 78.1%
2.7
F-Score
改良版 Piotroski 分析
7年ファンダメンタル
弱い • 2.7 / 9 ポイント
スコアレンジ (0-9)
8-9: 価値が優れている
6-7: 基礎体質が強い
4-5: 全体的に堅調
0-3: パフォーマンスが弱い
データ期間: 2019-2025

深度リサーチ

財務データ
決算説明会
財務レポート
ニュース
損益計算書
バランスシート
キャッシュフロー計算書
財務比率
変化率
損益計算書
直近12ヶ月
データなし